YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJWU5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,114
Award facts
- Contract value 100% obligated
- $1,113.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a broader $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a comprehensive product portfolio encompassing branded and generic prescription medications, biologics, vaccines, and medical consumables. The company holds a single-award IDC under the PPV-G GEN V program (contract SPE2DR) with a $499.999 billion ceiling value and a completion date of December 31, 2036, positioning it as one of multiple regional prime vendor contractors. The contractor's demonstrated performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, combined with its SAM registration since July 2001, reflects sustained capability to fulfill the diverse and specialized pharmaceutical requirements of the military medical system.
Quick answers
Who was awarded contract SPE2DR26FJWU5?
SPE2DR26FJWU5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FJWU5 worth?
The government has obligated $1,114 on SPE2DR26FJWU5.
Is contract SPE2DR26FJWU5 an order under another contract?
Yes. SPE2DR26FJWU5 is a delivery order under SPE2DR25D9330, an indefinite delivery contract.
Was contract SPE2DR26FJWU5 competed?
The extent of competition for SPE2DR26FJWU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award